| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/03/2007 | US7199244 Cyclic amine derivatives and methods of use |
| 04/03/2007 | US7199243 Antilipemic agents; anticholesterol agents; atherosclerosis; cardiovascular disorders; obesity; antidiabetic agents |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
| 04/03/2007 | US7199138 Substituted anthranilamides for controlling invertebrate pests |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199131 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce interferon-alpha biosynthesis or as a viricide or anticarcinogenic agent |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199118 potent and highly efficacious in potentiating AMPA-responses, show good lipophilicity and hence have good physicochemical properties, in particular ability to cross the blood/brain barrier |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 03/29/2007 | WO2007035874A1 Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof |
| 03/29/2007 | WO2007034144A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 03/29/2007 | WO2007034143A1 Quinazoline derivatives as anticancer agents |
| 03/29/2007 | WO2007033780A2 Thiazoles used as fungicides |
| 03/29/2007 | WO2006132914A3 Cyclobutyl amine derivatives |
| 03/29/2007 | WO2006125181A3 Piperidine derivatives and their use as stearoyl-coa desaturase modulators |
| 03/29/2007 | WO2006124447A3 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 03/29/2007 | WO2006123255A3 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/29/2007 | WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists |
| 03/29/2007 | WO2006108965A3 Npy antagonists, preparation and use |
| 03/29/2007 | WO2006060424A3 Inducible nitric oxide synthase dimerization inhibitors |
| 03/29/2007 | WO2006024841A3 Benzamide compounds |
| 03/29/2007 | US20070073058 Compound having thiol anchoring group, method of synthesizing the same, and molecular electronic device having molecular active layer formed using the compound |
| 03/29/2007 | US20070073056 4-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 03/29/2007 | US20070072919 Preparing perindopril by reacting 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanine and octahydro 1H-indole-2-carboxylic acid or its ester with a uronium salt (O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) in the presence of a tertiary amine in an aprotic solvent |
| 03/29/2007 | US20070072914 11- beta -hydroxysteroid dehydrogenase type 1 enzyme inhibitor; antidiabetic agent, antidepressant; metabolic syndrome, insulin resistance syndrome, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, atherosclerosis, dementia |
| 03/29/2007 | US20070072911 Indoles and azaindoles as antiviral agents |
| 03/29/2007 | US20070072901 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 |
| 03/29/2007 | US20070072878 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2-[5(6)-Amidino-2-benzimidazoyl]-5-(4-nitrophenyl)furan |
| 03/29/2007 | US20070072877 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2,5-Bis(2-methyl-4-N,N'-di-BOCguanidinophenyl)furan |
| 03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
| 03/29/2007 | US20070072871 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 03/29/2007 | US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors |
| 03/29/2007 | US20070072853 Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof |
| 03/29/2007 | US20070072850 Pesticides |
| 03/29/2007 | US20070072840 Polymorphic forms of quetiapine |
| 03/29/2007 | CA2623267A1 Thiazoles used as fungicides |
| 03/28/2007 | EP1767535A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 03/28/2007 | EP1765817A1 Thiazolinone unsubstituted quinolines |
| 03/28/2007 | EP1765816A1 Substituted 1-propiolylpiperazines having an affinity for the mglur5 receptor in order to treat painful conditions |
| 03/28/2007 | EP1765815A2 New compounds useful for treating cns disorders |
| 03/28/2007 | EP1765814A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists |
| 03/28/2007 | EP1765810A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/28/2007 | EP1765805A2 Cgrp receptor antagonists |
| 03/28/2007 | EP1765798A2 1,2,4- thiadiazole compounds and pests controlling composition containing the same |
| 03/28/2007 | EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/28/2007 | EP1765793A1 Cetp inhibitors |
| 03/28/2007 | EP1765789A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 03/28/2007 | EP1765788A2 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases |
| 03/28/2007 | CN1938305A 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof |
| 03/28/2007 | CN1938300A Oxadiazolone derivatives as PPAR delta agonists |
| 03/28/2007 | CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 03/28/2007 | CN1938294A Novel pyrrolidine-3,4-dicarboxamide derivatives |
| 03/28/2007 | CN1938291A Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 03/28/2007 | CN1938281A Ion channel modulators |
| 03/28/2007 | CN1938279A Modulators of atp-binding cassette transporters |
| 03/28/2007 | CN1938274A Novel piperidines as chemokine modulators (CCR) |
| 03/28/2007 | CN1938273A Tetrahydrocarbazoles and derivatives |
| 03/28/2007 | CN1938031A Biaryl substituted pyrazinones as sodium channel blockers |
| 03/28/2007 | CN1938022A Ion channel modulators |
| 03/28/2007 | CN1938021A Ion channel modulators |
| 03/28/2007 | CN1938020A Ion channel modulators |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/27/2007 | US7196199 Phenoxypropylamine compounds |
| 03/27/2007 | US7196194 for color photography |
| 03/27/2007 | US7196109 Piperidine-1-carboxylic acid (6,7-difluoro-5-phenyl-1H-indazol-3-yl)amide; especially for treating neurodegenerative diseases; kinase inhibitor |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
| 03/27/2007 | US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196078 Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7195885 Hepatitis C virus assays |
| 03/27/2007 | CA2251820C Substituted benzylamines and their use for the treatment of depression |
| 03/27/2007 | CA2208018C Sulfonamides |
| 03/27/2007 | CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
| 03/27/2007 | CA2169145C Substituted benzisoxazole and benzisothiazole herbicidal agents |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007032263A1 Composition containing chloromethyl phosphate derivative with improved stability and process for producing the same |
| 03/22/2007 | WO2007032028A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 03/22/2007 | WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/22/2007 | WO2007031513A1 Pesticide thiazolyloxy substituted phenylamidine derivatives |
| 03/22/2007 | WO2005072308A3 Cgrp receptor antagonists |
| 03/22/2007 | US20070066821 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 03/22/2007 | US20070066820 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 03/22/2007 | US20070066666 Thiazole compounds |
| 03/22/2007 | US20070066665 Compounds and methods for the diagnosis and treatment of amyloid associated diseases |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066662 Catalytically reducing 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzylidene}-2,4-thiazolidinedione or its salt or hydrate at above 70 degrees C. using a hydrogen pressure above 20 psi, to form 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl}-2,4-thiazolidinedione |
| 03/22/2007 | US20070066655 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists |
| 03/22/2007 | US20070066651 Pyrazoline derivatives useful for the treatment of cancer |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066617 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly |
| 03/22/2007 | US20070066614 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |